As a member of the Institute for Cancer Research, Dr. Andras Lacko is involved in developing a delivery system for anti-cancer drugs that will effectively kill cancer cells and tumors while protecting normal tissue. He is currently working with Dr. Anil Sood of M.D. Anderson Cancer Center and Dr. Alan Remaley of the National Heart Lung and Blood Institute to advance this project toward clinical/human applications.